ACET FY 2020 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18M+1699.3% YoY

Gross Profit

$18M100.0% margin

Operating Income

-$39M-218.9% margin

Net Income

-$37M-204.9% margin

EPS (Diluted)

$-80.16

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$43M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$154M

Total Liabilities

$44M

Stockholders' Equity

$110M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$995,000	+1699.3%
Gross Profit	$18M	$995,000	+1699.3%
Operating Income	-$39M	-$31M	-24.9%
Net Income	-$37M	-$28M	-30.4%